$XNCR
Xencor Inc

2018 Q4 Form 10-K Financial Statement

#000155837020001256 Filed on February 25, 2020

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2018 Q2
Revenue $11.56M $29.04M $0.00
YoY Change -61.71% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.500M $7.400M $5.000M
YoY Change 25.0% 76.19% 21.95%
% of Gross Profit
Research & Development $27.10M $20.95M $23.33M
YoY Change 32.84% 8.01% 38.06%
% of Gross Profit
Depreciation & Amortization $900.0K $800.0K $900.0K
YoY Change 50.0% 60.0% 80.0%
% of Gross Profit
Operating Expenses $32.60M $28.39M $28.29M
YoY Change 31.45% 20.29% 34.71%
Operating Profit -$21.08M $651.0K -$28.29M
YoY Change
Interest Expense $2.800M $2.600M $2.500M
YoY Change 180.0% 160.0% 150.0%
% of Operating Profit 399.39%
Other Income/Expense, Net $100.0K $2.499M $2.421M
YoY Change -200.0% 2399.0%
Pretax Income -$18.20M $3.150M -$25.87M
YoY Change -388.89% -114.0% 249.58%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$18.20M $3.150M -$25.87M
YoY Change -345.91% -113.88% 235.96%
Net Earnings / Revenue -157.36% 10.85%
Basic Earnings Per Share -$0.32 $0.06 -$0.46
Diluted Earnings Per Share -$0.32 $0.05 -$0.46
COMMON SHARES
Basic Shares Outstanding 55.97M 55.68M
Diluted Shares Outstanding 58.31M 55.68M

Balance Sheet

Concept 2018 Q4 2018 Q3 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $294.4M $271.6M $255.4M
YoY Change 31.37% 29.33% 35.49%
Cash & Equivalents $26.25M $35.00M $35.29M
Short-Term Investments $268.1M $236.6M $220.1M
Other Short-Term Assets $10.40M $12.10M $12.10M
YoY Change 85.71% 72.86% 59.21%
Inventory
Prepaid Expenses
Receivables $10.19M $2.500M $1.300M
Other Receivables $800.0K $700.0K $700.0K
Total Short-Term Assets $315.7M $286.9M $269.5M
YoY Change 36.74% 31.73% 27.73%
LONG-TERM ASSETS
Property, Plant & Equipment $11.81M $9.700M $9.400M
YoY Change 66.38% 59.02% 141.03%
Goodwill
YoY Change
Intangibles $11.97M
YoY Change
Long-Term Investments $236.1M $276.2M $300.0M
YoY Change 69.61% 69.34% 57.73%
Other Assets $311.0K $300.0K $300.0K
YoY Change 3.67% 0.0% 50.0%
Total Long-Term Assets $261.0M $298.7M $322.0M
YoY Change 63.84% 65.48% 56.92%
TOTAL ASSETS
Total Short-Term Assets $315.7M $286.9M $269.5M
Total Long-Term Assets $261.0M $298.7M $322.0M
Total Assets $576.7M $585.6M $591.5M
YoY Change 47.8% 47.02% 42.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.797M $6.000M $4.900M
YoY Change -44.97% -9.09% -33.78%
Accrued Expenses $9.662M $5.700M $5.900M
YoY Change 75.67% 23.91% 47.5%
Deferred Revenue $40.08M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $53.85M $52.00M $71.20M
YoY Change -25.92% -48.16% -33.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.200M $1.300M $1.100M
YoY Change 9.09% -82.43% -85.14%
Total Long-Term Liabilities $1.200M $1.300M $1.100M
YoY Change 9.09% -82.43% -85.14%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.85M $52.00M $71.20M
Total Long-Term Liabilities $1.200M $1.300M $1.100M
Total Liabilities $55.05M $53.30M $72.30M
YoY Change -25.3% -50.51% -37.02%
SHAREHOLDERS EQUITY
Retained Earnings -$323.3M
YoY Change
Common Stock $563.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $521.7M $532.3M $519.2M
YoY Change
Total Liabilities & Shareholders Equity $576.7M $585.6M $591.5M
YoY Change 47.8% 47.02% 42.12%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2018 Q2
OPERATING ACTIVITIES
Net Income -$18.20M $3.150M -$25.87M
YoY Change -345.91% -113.88% 235.96%
Depreciation, Depletion And Amortization $900.0K $800.0K $900.0K
YoY Change 50.0% 60.0% 80.0%
Cash From Operating Activities -$16.80M -$10.30M -$28.50M
YoY Change 150.75% 194.29% 120.93%
INVESTING ACTIVITIES
Capital Expenditures -$3.400M -$1.400M -$1.600M
YoY Change 78.95% -54.84% 45.45%
Acquisitions
YoY Change
Other Investing Activities $10.30M $7.300M -$188.6M
YoY Change -4.63% -8.75% -1879.25%
Cash From Investing Activities $6.800M $5.900M -$190.2M
YoY Change -24.44% 20.41% -2123.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.100M 4.200M 2.300M
YoY Change 83.33% 320.0% 109.09%
NET CHANGE
Cash From Operating Activities -16.80M -10.30M -28.50M
Cash From Investing Activities 6.800M 5.900M -190.2M
Cash From Financing Activities 1.100M 4.200M 2.300M
Net Change In Cash -8.900M -200.0K -216.4M
YoY Change -406.9% -108.33% 8916.67%
FREE CASH FLOW
Cash From Operating Activities -$16.80M -$10.30M -$28.50M
Capital Expenditures -$3.400M -$1.400M -$1.600M
Free Cash Flow -$13.40M -$8.900M -$26.90M
YoY Change 179.17% 2125.0% 127.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
CY2018Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
CY2018Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56902301
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56279542
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019 xncr Defined Contribution Plan Annual Vesting Percentage Over Vesting Term
DefinedContributionPlanAnnualVestingPercentageOverVestingTerm
0.33
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0001326732
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Type
DocumentType
10-K
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity File Number
EntityFileNumber
001-36182
CY2019 dei Entity Registrant Name
EntityRegistrantName
Xencor, Inc
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1622502
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
111 West Lemon Avenue
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Monrovia
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91016
CY2019 dei City Area Code
CityAreaCode
626
CY2019 dei Local Phone Number
LocalPhoneNumber
305-5900
CY2019 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2019 dei Trading Symbol
TradingSymbol
XNCR
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019Q2 dei Entity Public Float
EntityPublicFloat
2291908831
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56943858
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
50312000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26246000
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
479470000
CY2018Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
268115000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21574000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10187000
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
502000
CY2018Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
804000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6547000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10375000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
558405000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
315727000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15805000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11813000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14421000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11969000
CY2019Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
71526000
CY2018Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
236108000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
311000
CY2019Q4 us-gaap Assets
Assets
670250000
CY2019Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
402000
CY2018Q4 us-gaap Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
804000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9380000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
311000
CY2018Q4 us-gaap Assets
Assets
576732000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10189000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3797000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8995000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9662000
CY2018Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
315000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2169000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45205000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40079000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
66558000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
53853000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1198000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8565000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1926000
CY2019Q4 us-gaap Liabilities
Liabilities
77049000
CY2018Q4 us-gaap Liabilities
Liabilities
55051000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56902301
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56279542
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
569000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
563000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
887873000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
845366000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1161000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-971000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-296402000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-323277000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
593201000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
521681000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
670250000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
576732000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156700000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40603000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46150000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
118590000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
97501000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71772000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24286000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22472000
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17501000
CY2019 us-gaap Operating Expenses
OperatingExpenses
142876000
CY2018 us-gaap Operating Expenses
OperatingExpenses
119973000
CY2017 us-gaap Operating Expenses
OperatingExpenses
89273000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
13824000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-79370000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-43123000
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13619000
CY2018 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9086000
CY2017 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
4181000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-256000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-125000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13363000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8961000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4174000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27187000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-70409000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-38949000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
312000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-463000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
26875000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-70409000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-38486000
CY2019 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
2132000
CY2018 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
837000
CY2017 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-367000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29007000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-69572000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38853000
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.31
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.31
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56531439
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53942116
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46817756
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58467880
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53942116
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46817756
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
337933000
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2797000
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
936000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38853000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13651000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
316464000
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
245504000
CY2018 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7617000
CY2018 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1120000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-69572000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20548000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
521681000
CY2019 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9269000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1393000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
29007000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31851000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
593201000
CY2019 us-gaap Profit Loss
ProfitLoss
26875000
CY2018 us-gaap Profit Loss
ProfitLoss
-70409000
CY2017 us-gaap Profit Loss
ProfitLoss
-38486000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4298000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3251000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2030000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
4321000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
394000
CY2017 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2845000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
31851000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
20548000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
13651000
CY2019 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
221000
CY2018 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
239000
CY2017 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
396000
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-8000
CY2018 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-102000
CY2017 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-83000
CY2018 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-74000
CY2019 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
11321000
CY2018 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
9045000
CY2017 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-7474000
CY2019 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
387000
CY2018 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
535000
CY2017 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
307000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3828000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4769000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2705000
CY2019 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-704000
CY2018 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
84000
CY2017 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1524000
CY2018 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
46000
CY2017 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
161000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6392000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3072000
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2989000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-667000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4182000
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1212000
CY2019 xncr Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-1513000
CY2018 xncr Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
398000
CY2017 xncr Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
589000
CY2018 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-157000
CY2017 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
91000
CY2019 xncr Increase Decrease In Lease Liabilities And Right Of Use Assets
IncreaseDecreaseInLeaseLiabilitiesAndRightOfUseAssets
1354000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
7052000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79756000
CY2018 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-20039000
CY2017 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-19350000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
64374000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7617000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33597000
CY2019 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
456923000
CY2018 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
222125000
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
115757000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
9000
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
496855000
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
377840000
CY2017 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
76529000
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3685000
CY2018 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1935000
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1967000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7353000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7212000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5311000
CY2018 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-86000
CY2017 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
86000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50970000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-164767000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
31864000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
9269000
CY2017 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2797000
CY2019 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1393000
CY2018 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1120000
CY2017 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
936000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
260245000
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
14741000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10662000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
254241000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3733000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24066000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9718000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2000000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26246000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16528000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14528000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50312000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26246000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16528000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
11000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
16000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
13000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
400000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
233000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
969000
CY2019 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
2132000
CY2018 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
837000
CY2017 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-367000
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates include useful lives of long-lived assets, the periods over which certain revenues and expenses will be recognized including collaboration revenue recognized from non-refundable upfront licensing payments, the amount of non-cash compensation costs related to share-based payments to employees and non-employees and the period over which these costs are expensed. </p>
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
47100000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40100000
CY2019Q4 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
2700000
CY2018Q4 us-gaap Interest Receivable Noncurrent
InterestReceivableNoncurrent
2300000
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Concentrations of Risk</span></p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cash, cash equivalents and marketable debt securities are financial instruments that potentially subject the Company to concentrations of risk. We invest our cash in corporate debt securities and U.S. sponsored agencies with strong credit ratings. We have established guidelines relative to diversification and maturities that are designed to help ensure safety and liquidity. These guidelines are periodically reviewed to take advantage of trends in yields and interest rates.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. We have never experienced any losses related to these balances. Amounts on deposit in excess of federally insured limits at December 31, 2019 and 2018 approximated $50.0 million and $26.0 million, respectively.</p><p style="font-family:'Times New Roman';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">We have payables with two service providers that represent 48% of our total payables and four service providers that represented 49% of our total payables at December 31, 2019 and 2018, respectively. We rely on three critical suppliers for the manufacture of our drug product for use in our clinical trials. While we believe that there are alternative vendors available, a change in manufacturing vendors could cause a delay in the availability of drug product and result in a delay of conducting and completing our clinical trials. No other vendor accounted for more than 10% of total payables at December 31, 2019 or 2018.</p>
CY2019Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
50000000.0
CY2018Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
26000000.0
CY2019 xncr Number Of Primary Criterias To Determine Capitalization Of Patent
NumberOfPrimaryCriteriasToDetermineCapitalizationOfPatent
3
CY2019 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
200000
CY2018 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
200000
CY2017 us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
400000
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
20772000
CY2018Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
17374000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14421000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11969000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
800000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1009000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
912000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
880000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
809000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
647000
CY2019Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
2365000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6622000
CY2017Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20500000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13700000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31900000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
26875000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-70409000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38486000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56531439
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53942116
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46817756
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.31
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
26875000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-70409000
CY2017 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-38486000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56531439
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
53942116
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46817756
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1936441
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58467880
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53942116
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46817756
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.31
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q4 xncr Cash And Cash Equivalents And Marketable Securities Amortized Cost
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
581834000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1201000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
30000
CY2019Q4 us-gaap Investments
Investments
583005000
CY2019Q4 us-gaap Investments
Investments
583005000
CY2018Q4 xncr Cash And Cash Equivalents And Marketable Securities Amortized Cost
CashAndCashEquivalentsAndMarketableSecuritiesAmortizedCost
523454000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
188000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1149000
CY2018Q4 us-gaap Investments
Investments
522493000
CY2018Q4 us-gaap Investments
Investments
522493000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
478338000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
479470000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
71487000
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
71526000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
549825000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
550996000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
46303000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
24000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
13992000
CY2019Q4 xncr Debt Securities Available For Sale Continuous Unrealized Gain Loss Position12 Months Or Longer Accumulated Gain Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedGainLossPosition12MonthsOrLongerAccumulatedGainLoss
-6000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
260891000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
982000
CY2018Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
134635000
CY2018Q4 xncr Debt Securities Available For Sale Continuous Unrealized Gain Loss Position12 Months Or Longer Accumulated Gain Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedGainLossPosition12MonthsOrLongerAccumulatedGainLoss
-167000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28410000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21239000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12605000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9426000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15805000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11813000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3400000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2400000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1200000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-500000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
300000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
5709000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14795000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-13243000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2549000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-4767000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1806000
CY2019 xncr Income Tax Reconciliation Research And Development Credit
IncomeTaxReconciliationResearchAndDevelopmentCredit
-6747000
CY2018 xncr Income Tax Reconciliation Research And Development Credit
IncomeTaxReconciliationResearchAndDevelopmentCredit
-6170000
CY2017 xncr Income Tax Reconciliation Research And Development Credit
IncomeTaxReconciliationResearchAndDevelopmentCredit
-5554000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
1927000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
444000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
2709000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Cuts And Jobs Act Of2017 Amount
EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017Amount
19596000
CY2019 xncr Effective Income Tax Rate Reconciliation Tax Credit State Amount
EffectiveIncomeTaxRateReconciliationTaxCreditStateAmount
-1725000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-301000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
414000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
720000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-4550000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
24874000
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2885000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
312000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-463000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
36891000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
49889000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
28415000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
23151000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
334000
CY2018Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
207000
CY2018Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
269000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
4788000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1097000
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
11215000
CY2018Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
11222000
CY2019Q4 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
64000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
81707000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
85835000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
77389000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
82537000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4318000
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3298000
CY2019Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Patent Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts
3736000
CY2018Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Patent Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts
3142000
CY2019Q4 xncr Deferred Tax Liabilities License Costs
DeferredTaxLiabilitiesLicenseCosts
229000
CY2018Q4 xncr Deferred Tax Liabilities License Costs
DeferredTaxLiabilitiesLicenseCosts
125000
CY2019Q4 xncr Deferred Tax Liabilities Capitalized Legal Costs
DeferredTaxLiabilitiesCapitalizedLegalCosts
26000
CY2018Q4 xncr Deferred Tax Liabilities Capitalized Legal Costs
DeferredTaxLiabilitiesCapitalizedLegalCosts
31000
CY2019Q4 us-gaap Deferred Tax Liabilities Other Comprehensive Income
DeferredTaxLiabilitiesOtherComprehensiveIncome
327000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4318000
CY2018Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3298000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-5100000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31851000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20548000
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
3950965
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
17.79
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13651000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31851000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20548000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13651000
CY2019Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
7174319
CY2019 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y3M25D
CY2019Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
24.03
CY2019 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2703000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2588000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2208000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1352000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1371000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2282000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12504000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1770000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10734000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2169000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8565000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10734000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
2700000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
2600000
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2500000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.055
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156700000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40600000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46200000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156700000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40600000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46200000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156700000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40600000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46200000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
156700000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40600000
CY2017 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46200000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
47100000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40100000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45200000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1900000
CY2019 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.035
CY2019 xncr Defined Contribution Plan Vesting Period
DefinedContributionPlanVestingPeriod
P3Y
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
600000
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
500000
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111939000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19485000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21760000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3516000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
78244000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19572000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14276000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-30572000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
80045000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-16034000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-10224000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-26912000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.42
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.38
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
CY2018Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29039000
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11564000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-30649000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-28290000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
651000
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-21082000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-29493000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-25869000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
3150000
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-18197000
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32

Files In Submission

Name View Source Status
0001558370-20-001256-index-headers.html Edgar Link pending
0001558370-20-001256-index.html Edgar Link pending
0001558370-20-001256.txt Edgar Link pending
0001558370-20-001256-xbrl.zip Edgar Link pending
ex-10d33.htm Edgar Link pending
ex-10d33g001.jpg Edgar Link pending
ex-10d34.htm Edgar Link pending
ex-10d34g001.jpg Edgar Link pending
ex-23d1.htm Edgar Link pending
ex-31d1.htm Edgar Link pending
ex-31d2.htm Edgar Link pending
ex-32d1.htm Edgar Link pending
ex-32d2.htm Edgar Link pending
ex-4d3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xncr-20191231.xsd Edgar Link pending
xncr-20191231x10k128a17.htm Edgar Link pending
xncr-20191231x10k128a17004.jpg Edgar Link pending
xncr-20191231x10k128a17_htm.xml Edgar Link completed
xncr-20191231_cal.xml Edgar Link unprocessable
xncr-20191231_def.xml Edgar Link unprocessable
xncr-20191231_lab.xml Edgar Link unprocessable
xncr-20191231_pre.xml Edgar Link unprocessable